PRP4K and ovarian carcinoma: Corkery et al. (2018) first described the capacity for PRP4K to overcome anoikis using a novel xenotransplantation assay in zebrafish, and the ID8 mouse model of ovarian carcinoma (Corkery et al., 2018) (Figure 3B).